Latest FDA Stories
Transplant surgeon of the stars, Dr.
The publication of the analysis echoes recent FDA concerns that prescription low testosterone treatments are being used extensively to relieve low hormone levels normally associated with male
Coalition highlights momentum behind campaign for approval of first-ever drug for women's sexual dysfunction, launches new website for supporters to contact their elected representatives
With FDA's Approval of the First Biosimilar in the U.S., Groups Urge OMB to Work with FDA to Finalize Critical Naming Policy Supporting Patient Safety WASHINGTON, March 26, 2015 /PRNewswire-USNewswire/
Portable Medical Device Treats Depression, Anxiety and Insomnia NEW YORK, March 26, 2015 /PRNewswire/ -- Fisher Wallace Laboratories today announced that its popular neurostimulation
Approval allows children to receive a combination of two recommended vaccinations SWIFTWATER, Pa., March 25, 2015 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT:
Diabetic retinopathy in patients with DME is the fourth approved indication for EYLEA in the U.S. TARRYTOWN, N.Y., March 25, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
Attorneys representing nation testosterone lawsuits for the Onder Law Firm provide insight on new testosterone label requirements, including a stipulation that testosterone drug labels warn of
Intelligent Retinal Imaging Systems (IRIS), a retinal screening solution for primary care, has received clearance by the United States Food and Drug Administration (FDA), a distinction that comes
CAESAREA, Israel, March 24, 2015 /PRNewswire/ -- Asaf Alperovitz, Allium Medical CEO: "The FDA confirmed that Gardia successfully achieved all of the clinical endpoints
- Forsooth! indeed! originally a parenthetical phrase used in repeating the words of another with more or less contempt or disdain.